Inicio > BIGG > Resultado de la búsqueda

    Resultados: 3

    AGA clinical practice guideline on the role of biomarkers for the management of ulcerative colitis

    Singh, Siddharth; Ananthakrishnan, Ashwin N; Nguyen, Nghia H; Cohen, Benjamin L; Velayos, Fernando S; Weiss, Jennifer M; Sultan, Shahnaz; Siddique, Shazia M; Adler, Jeremy; Chachu, Karen A.
    Gastroenterology; 164 (3), 2023
    Biomarkers are used frequently for noninvasive monitoring and treatment decision making in the management of patients with ulcerative colitis (UC). This American Gastroenterological Association (AGA) guideline is intended to support practitioners in decisions about the use of biomarkers for the managemen...
    Colitis Ulcerosa/prevención & control, Biomarcadores, Endoscopía Gastrointestinal, Lactoferrina/análisis, Complejo de Antígeno L1 de Leucocito/análisis
    Texto completo

    The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy

    Nguyen, GC; Seow, CH; Maxwell, C; Huang, V; Leung, Y; Jones, J; Leontiadis, GI; Tse, F; Mahadevan, U; van der Woude, CJ.
    Gastroenterology; 150 (3), 2016
    "BACKGROUND & AIMS: The management of inflammatory bowel disease (IBD) poses a particular challenge during pregnancy because the health of both the mother and the fetus must be considered. METHODS: A systematic literature search identified studies on the management of IBD during pregnancy. The quality o...
    Inmunosupresores/administración & dosificación, Colitis Ulcerosa, Enfermedad de Crohn, Sustitución de Medicamentos, Gastroenterología, Servicios de Salud Materna, Atención Preconceptiva, Complicaciones del Embarazo, Medición de Riesgo, Factores de Riesgo, Resultado del Tratamiento, Enfermedades Inflamatorias del Intestino, Enfermedad de Crohn/diagnóstico, Enfermedad de Crohn/terapia, Complicaciones del Embarazo/diagnóstico, Complicaciones del Embarazo/terapia, Inmunosupresores/efectos adversos, Colitis Ulcerosa/diagnóstico, Colitis Ulcerosa/terapia
    Texto completo

    Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus

    Bressler, B; Marshall, J. K; Bernstein, C. N; Bitton, A; Jones, J; Leontiadis, G. I; Panaccione, R; Steinhart, A. H; Tse, F; Feagan, B.
    Gastroenterology; 148 (5), 2015
    BACKGROUND & AIMS:: The medical management of ulcerative colitis (UC) has improved through the development of new therapies and novel approaches that optimize existing drugs. Previous Canadian consensus guidelines addressed the management of severe UC in the hospitalized patient. We now present consensu...
    Colitis Ulcerosa/tratamiento farmacológico, Atención Ambulatoria, Mesalamina/uso terapéutico, Corticoesteroides/uso terapéutico, Probióticos/uso terapéutico
    Texto completo